Obesity Intervention Devices Market Report 2025 (Global Edition)

Global Obesity Intervention Devices Market Report 2024 Market Size Split by Device (Gastric Bands, Gastric Balloon, Gastric stimulation system), by End User (Hospitals, Clinics)

Obesity Intervention Devices Market Report Description

We have various report editions of Obesity Intervention Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Obesity Intervention Devices Market Insights Video

Competitive Landscape of the Obesity Intervention Devices Market

The obesity intervention devices market is highly competitive, with key players like Medtronic, Johnson & Johnson, and Boston Scientific leading the field. Competition is driven by technological innovation, with companies developing advanced surgical and non-surgical devices. Players focus on expanding their product portfolios, enhancing device efficacy, and improving patient outcomes. Strategic partnerships, mergers, and investments in R&D are common strategies to maintain market leadership and address the growing demand for effective obesity management solutions.

February 2024: Appalachian Regional Healthcare (ARH) in the United States has implemented advanced bariatric procedures using the state-of-the-art da Vinci Xi robotic system. The medical team at ARH performed the first Modified Duodenal Switch, known as SADI-S (Single Anastomosis Duodeno-ileostomy with sleeve gastrectomy), along with a Robotically Assisted Roux-En-Y Gastric Bypass (RYGB). (Source: https://www.arh.org/newsfeed/dr.-mehta-performs-advanced-bariatric-surgery-with-new-technology) February 2024: BariaTek Medical carried out the first human implant of the BariTon device. This novel device, which is introduced endoscopically, features both gastric and intestinal components. (Source: https://www.medicaldevice-network.com/news/bariatek-implants-first-device-that-aims-to-mimic-weight-loss-surgery/#:~:text=View%20all-,BariaTek's%20BariTon%20is%20a%20reversible%20implant%20that%20consists%20of%20a,endoscopy%20in%20an%20outpatient%20clinic.) January 2024: Teleflex Incorporated introduced the Titan SGS Stapler, which includes staple line reinforcement (SLR). This new product is designed for bariatric surgeons, particularly those who prefer added support during sleeve gastrectomy procedures. (Source: https://investors.teleflex.com/news/news-details/2024/Teleflex-now-offers-its-Titan-SGS-Staplerwith-Staple-Line-Reinforcement/default.aspx)

Top Companies Market Share in Obesity Intervention Devices Industry: (In no particular order of Rank)

• Medtronic plc
• Johnson & Johnson
• Boston Scientific Corporation
• Ethicon Endo-Surgery (a subsidiary of Johnson & Johnson)
• Apollo Endosurgery
• Inc.
• Olympus Corporation
• Baronova
• Inc.
• Innova Medical Group
• TransEnterix
• Inc.
• ReShape Lifesciences Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Obesity Intervention Devices Market

Which Region Dominates the Obesity Intervention Devices Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024. It accounted for around 40% of the global revenue due to the region's high obesity rates and advanced healthcare infrastructure. The region’s strong focus on innovative medical technologies, extensive research and development, and widespread availability of obesity management solutions contribute to its dominant position. Additionally, favorable regulatory environments and substantial investments in healthcare drive the adoption of advanced obesity intervention devices, further solidifying North America's leading market share.

Which Region is Expanding at the Fastest CAGR?

The Asia Pacific region is growing at the fastest CAGR in the obesity intervention devices market due to rapid urbanization, changing lifestyles, and increasing obesity rates. Economic development and rising disposable incomes drive investments in healthcare technologies. Additionally, improving healthcare infrastructure and growing awareness of obesity-related health risks boost demand for effective intervention devices. The expansion of medical facilities and increasing focus on preventive healthcare contribute to the region’s accelerated market growth.

The current report Scope analyzes Obesity Intervention Devices Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Obesity Intervention Devices Market

According to Cognitive Market Research, the global Obesity Intervention Devices market size was estimated at USD 256.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 102.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Obesity Intervention Devices market with a market size of USD 80.86 million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. The nation's rising obesity rates, increasing awareness of health risks, and advancements in medical technology is driving the Obesity Intervention Devices market.
• The Canada Obesity Intervention Devices market had a market share of USD 12.30 million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. Canada's competitive business environment is driving the Obesity Intervention Devices market.
• The Mexico Obesity Intervention Devices market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 9.33 million in 2024.

Europe Obesity Intervention Devices Market

According to Cognitive Market Research, the global Obesity Intervention Devices market size was estimated at USD 256.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 76.86 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.5% from 2024 to 2031.

• The United Kingdom Obesity Intervention Devices market had a market share of USD 12.91 million in 2024 and is projected to grow at a CAGR of 5.3% during the forecast period. In the UK, Obesity Intervention Devices sales witness an upswing due to increasing obesity rates and a rising emphasis on preventive healthcare.
• The France Obesity Intervention Devices market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 7.07 million in 2024.
• According to Cognitive Market Research, the German Obesity Intervention Devices market size was valued at USD 15.22 million in 2024 and is projected to grow at a CAGR of 4.7% during the forecast period. In Germany, Obesity Intervention Devices surged due to the presence of major market players.
• The Italy Obesity Intervention Devices market is projected to witness growth at a CAGR of 3.9% during the forecast period, with a market size of USD 6.61 million in 2024.
• The Russia Obesity Intervention Devices market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD 11.91 million in 2024.
• The Spain Obesity Intervention Devices market is projected to witness growth at a CAGR of 3.6% during the forecast period with a market size of USD 6.30 million in 2024
• The Luxembourg Obesity Intervention Devices market is projected to witness growth at a CAGR of 4.6% during the forecast period, with a market size of USD 2.38 million in 2024.
• The Portugal Obesity Intervention Devices market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 1.61 million in 2024.
• The Greece Obesity Intervention Devices market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 0.92 million in 2024.
• Rest of Europe's Obesity Intervention Devices market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 11.91 million in 2024.

Asia Pacific Obesity Intervention Devices Market

According to Cognitive Market Research, the global Obesity Intervention Devices market size was estimated at USD 256.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 58.93 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Obesity Intervention Devices market size was valued at USD 26.52 million in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. Obesity Intervention Devices surged in China due to rapid urbanization, changing dietary habits, and increasing obesity rates.
• The Japan Obesity Intervention Devices market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 8.13 million in 2024.
• The India Obesity Intervention Devices market had a market share of USD 7.07 million in 2024 and is projected to grow at a CAGR of 9.8% during the forecast period. India's expanding healthcare infrastructure is driving the Obesity Intervention Devices market.
• The South Korean Obesity Intervention Devices market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 5.89 million in 2024.
• The Australian Obesity Intervention Devices market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 3.06 million in 2024.
• The South East Asia Obesity Intervention Devices market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 4.07 million in 2024.
• The Rest of Asia Pacific Obesity Intervention Devices market is projected to witness growth at a CAGR of 7.8% during the forecast period, with a market size of USD 4.18 million in 2024.

South America Obesity Intervention Devices Market

According to Cognitive Market Research, the global Obesity Intervention Devices market size was estimated at USD 256.2 Million, out of which the Latin America market has more than 5% share of the global revenue with a market size of USD 12.81 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2031. .

• According to Cognitive Market Research, the Brazil Obesity Intervention Devices market size was valued at USD 5.48 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. Obesity Intervention Devicess flourished in Brazil due rising obesity rates and increasing health awareness.
• Argentina's Obesity Intervention Devices market had a market share of USD 2.15 million in 2024 and is projected to grow at a CAGR of 6.3% during the forecast period. Argentina's improving healthcare infrastructure augment the demand.
• Colombia Obesity Intervention Devices market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 1.14 million in 2024.
• Peru Obesity Intervention Devices market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 1.05 million in 2024.
• Chile Obesity Intervention Devices market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 0.92 million in 2024.
• The Rest of Latin America's Obesity Intervention Devices market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 2.06 million in 2024.

Middle East and Africa Obesity Intervention Devices Market

According to Cognitive Market Research, the global Obesity Intervention Devices market size was estimated at USD 256.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 5.12 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031..

• The GCC Countries Obesity Intervention Devices market is projected to witness growth at a CAGR of 6.5% during the forecast period, with a market size of USD 2.19 million in 2024. Obesity Intervention Devices sales flourish due to the presence of major market players.
• The Egypt Obesity Intervention Devices market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 0.54 million in 2024.
• The South Africa Obesity Intervention Devices market is projected to witness growth at a CAGR of 6.7% during the forecast period, with a market size of USD 0.81 million in 2024. Obesity Intervention Devices sales flourish in South Africa due to rising obesity rates and increasing healthcare investments.
• The Turkey Obesity Intervention Devices market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 0.44 million in 2024.
• The Nigeria Obesity Intervention Devices market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 0.54 million in 2024.
• The Rest of MEA Obesity Intervention Devices market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 0.60 million in 2024.

Obesity Intervention Devices Market Analysis

Obesity Intervention Devices Market Device Segment Analysis

According to Cognitive Market Research, Gastric Bands stands out as the dominant category. Gastric bands captured the largest market share in the obesity intervention devices market due to their minimally invasive nature and effective weight loss outcomes. These devices are adjustable, allowing for personalized treatment and gradual weight loss, which appeals to both patients and healthcare providers. Their established track record, combined with a relatively lower risk of complications compared to other surgical options, drives widespread adoption and market dominance.

The gastric balloon device is growing at the highest CAGR in the obesity intervention devices market due to its non-surgical, minimally invasive approach and favorable safety profile. It offers an effective, temporary weight loss solution with lower risk and recovery time compared to surgical options. Increasing patient preference for less invasive procedures and growing awareness about its benefits contribute to its rapid adoption and market growth, driving the highest CAGR in the sector.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Obesity Intervention Devices Industry. Request a Free Sample PDF!

Obesity Intervention Devices Market End User Segment Analysis

According to Cognitive Market Research, the dominant category is Hospitals. Hospitals captured the largest market share in the obesity intervention devices market due to their capacity to offer comprehensive, advanced obesity treatments and surgical procedures. Hospitals are equipped with specialized facilities, experienced medical teams, and support systems essential for complex interventions. Additionally, they provide a wide range of obesity management solutions, including surgical and non-surgical options, which drives their dominance in the market. Their central role in obesity care and treatment contributes to their leading market share.

Clinics are growing at the highest CAGR in the obesity intervention devices market due to their increasing focus on outpatient and minimally invasive procedures. They offer specialized, accessible, and personalized weight management solutions, often with shorter wait times compared to hospitals. The rise of weight loss and metabolic clinics, combined with growing patient preference for less invasive treatments and direct care, drives the rapid expansion and adoption of obesity intervention devices in clinic settings.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion